George Washington University Hematology Update Symposium 2025

A concentrated, practice-focused update covering both benign and malignant hematology. Case-based lectures translate the latest evidence and guidelines into clear diagnostic pathways, treatment algorithms, and toxicity management you can apply immediately in clinic, hospital, and infusion settings.
What You Will Learn

Streamlined workups for anemia, cytopenias, coagulopathies, and thrombophilias

Evidence-based VTE care: anticoagulant selection, duration, peri-procedural management

Current standards and emerging options in leukemia, lymphoma, and myeloma

Transfusion medicine pearls: product selection, thresholds, reactions, and stewardship

Targeted agents and immunotherapies (BTK/BCL2 inhibitors, bispecifics, CAR-T): when to use and how to manage adverse events

Supportive care essentials: infection prophylaxis, tumor lysis risk mitigation, survivorship, and quality measures

Event Details

Format: Live, case-based lectures with board-style Q&A and practical take-home checklists

Structure: Thematic sessions (benign, malignant, thrombosis/hemostasis, transfusion, supportive care) with concise summaries for rapid reference

Access: Designed for quick implementation in community and academic settings

Who Should AttendHematologists/oncologists, hospitalists, internists, advanced practice providers, pharmacists, fellows/trainees, and infusion-center leaders seeking a high-yield, clinically oriented hematology refresh.
Why Attend

Convert complex trials and guidelines into simple, usable algorithms

Update diagnostics, therapeutics, and toxicity management across the hematology spectrum

Leave with pragmatic tools that improve safety, efficiency, and patient outcomes

 
+ Topics:

Saturday, February 15, 2025- Hyatt Regency Bethesda- Salons I-II

File
TIME
TOPIC
PRESENTER

07:00 AM – 08:00 AM
Breakfast | Visit Exhibit Hall- Salon III-IV
Exhibitors | Attendees

1
08:00 AM – 08:15 AM
Welcome | Introduction to Program
Robert S. Siegel, MD
Professor of Medicine, Associate Center Director for Education and Training,
The George Washington University, GW Cancer Center

2
08:15 AM – 09:00 AM
Myeloproliferative Neoplasms
Ayalew Tefferi, MD
Barbara Woodward Lips Professor of Medicine
Mayo Clinic

 
3
09:00 AM – 10:00 AM
Multiple Myeloma
Kenneth Anderson, MD
Kraft Family Professor of Medicine
Dana-Farber Cancer Institute,
Harvard Medical School

10:00 AM – 10:15 AM
Break | Visit Exhibit Hall- Salon III-IV
Exhibitors | Attendees

4
10:15 AM – 11:00 AM
Disorders of Coagulation
Kenneth A. Bauer, MD
Professor of Medicine, Harvard Medical School
Beth Israel Deaconess Medical Center

5
11:00 AM – 11:45 AM
Acute Myeloid Leukemia
Samah Nassereddine, MD
Assistant Professor of Medicine, The George Washington University, GW Cancer Center

 
6
11:45 AM – 12:30 PM
Chronic Lymphocytic Leukemia
Imad A. Tabbara, MD, FACP
Chief, Division of Hematology/Oncology of DeCesaris Cancer Institute,
Anne Arundel Medical Center, Clinical Professor of Medicine
George Washington University

12:30 PM – 01:30 PM
Lunch | Visit Exhibit Hall- Salon III-IV
Exhibitors | Attendees

12:30 PM – 01:30 PM
Lunch Product Forum sponsored by (tbc)

7
01:30 PM – 02:30 PM
Lymphoma
Nina Delaney Wagner-Johnston, MD
Director of Lymphoma Drug Development, The Sidney Kimmel Comprehensive Cancer Center, Professor of Oncology, The Johns Hopkins University School of Medicine

8
02:30 PM – 03:15 PM
Bone Marrow Failure
Mrinal S. Patnaik, MD
Chair, Acute Leukemia and Myeloid Neoplasms
Scientific Director of the Epigenetics Developmental Laboratory and Epigenomics Program
Associate Professor of Medicine
College of Medicine, Mayo Clinic

9
03:15 PM – 03:45 PM
Chronic Myelomonocytic Leukemia
Ayalew Tefferi, MD
Barbara Woodward Lips Professor of Medicine
Mayo Clinic

 
10
03:45 PM – 4:00 PM
Closing Remarks | Adjournment
Robert S. Siegel, MD
Professor of Medicine, Associate Center Director for Education and Training,
The George Washington University, GW Cancer Center